Anti-tumor vaccine efficacy depends on adjuvant type and associates with induced IgG subclass and glycosylation profiles.
Saved in:
| Title: | Anti-tumor vaccine efficacy depends on adjuvant type and associates with induced IgG subclass and glycosylation profiles. |
|---|---|
| Authors: | Lehrian, Selina1 (AUTHOR), Wasynczuk, Anna2 (AUTHOR), Petry, Janina1 (AUTHOR), Guderian, Melanie3 (AUTHOR), Nouta, Jan2 (AUTHOR), Buhre, Jana Sophia1 (AUTHOR), Lunding, Hanna B.1 (AUTHOR), Köcher, Philipp1 (AUTHOR), Schumacher, Hannah Franziska1 (AUTHOR), Dühring, Lara1 (AUTHOR), Kurwahn, Kathleen4 (AUTHOR), Manzhula, Kristina1 (AUTHOR), Manz, Rudolf4 (AUTHOR), Bartsch, Yannic C.3 (AUTHOR), Wuhrer, Manfred2 (AUTHOR), Ehlers, Marc1,5 (AUTHOR) marc.ehlers@uksh.de |
| Source: | Experimental Hematology & Oncology. 10/6/2025, Vol. 14 Issue 1, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
